Search

everythinglearnresearchcommunity

for

Search:↓

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

A multidisciplinary approach is crucial for effectively managing hair loss linked to endocrine and gynecological disorders.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Iron deficiency might be linked to hair loss, but more research is needed.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Vitamin and iron deficiencies are similar in both surgeries, with standard supplementation recommended.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The treatment improved menstrual flow and reduced ovarian cysts in mild to moderate PCOS cases.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Mais estudos são necessários para garantir a eficácia e qualidade dos tratamentos de alopecia com plantas medicinais.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.